Libido
- Manufacturer
- ProBlen
- Effective date
- 2021-01-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:14:09
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Equal Parts Of: Damiana 3X, Galium 3X, Glandula Suprarenalis 12X, Hepar 6X, Hypophysis 12X, Korean Ginseng 1X, Nuphar 2X, Orchitinum 6X, Phosphoricum ac 200C, Populus Trem 3X, Testosterone 30X.
INDICATIONS & USAGE SECTION
Indications: Temporarily supports the body to rebalance libido function and support sexual desire. Symptoms may include: Decreased sex drive and vitality, lack of ambition or vigor.
WARNINGS SECTION
Warnings: Not for use on children. If symptoms continue to recur, or if sleeplessness persists continuously for more than two weeks, consult a physician. Insomnia may be a symptom of a serious underlying medical illness. As with all medicines, if you are pregnant or breastfeeding, consult a health professional before using this product. In case of overdose, get medical help or contact a Poison Control Center right away.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions: Adults: Hold the spray-top close to your open mouth and spray twice directly under your tongue, three times a day. Some people notice improvement within two or three weeks, others take longer.
OTHER SAFETY INFORMATION
Tamper Evident: There is a seal around the neck of the bottle. Do not use if seal is broken or missing.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Organic Alcohol 20% v/v, Purified Water
OTC - QUESTIONS SECTION
Distributed By ProBlen: (888) 326-2121 www. problen.com
3021 Ridge Rd. Rockwall, TX 75032
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC: 43853-0019-1
LIBIDO
HOMEOPATHIC ORGANOTHERAPY
1.0 FL OZ. (30ML) 20% ALCOHOL
ProBLEN
OTC - PURPOSE SECTION
Temporarily supports the body to rebalance libido function and support sexual desire.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2db4fc38-a116-b0ab-3dae-57df54e5f212 | Product name | 2 | 20250121 |
| 386d1b2a-e9b7-0c83-111f-2a77b92895b3 | Product name | 5 | 20240422 |
| 7d55b53c-798b-47ae-992b-3921493a8303 | Product name | 1 | 20230322 |
| 8d753fd6-75b2-4f12-bcbf-339392960afa | Product name | 1 | 20230303 |
| 4fbda828-a5be-46fe-83ec-a88da4359919 | Product name | 1 | 20230104 |
| 93cc9bee-8bdc-273d-ec7f-c2c52535317a | Product name | 7 | 20210902 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 5 | 20210601 |
| f4f0889f-ee8b-471f-9a37-02a035280637 | Product name | 1 | 20200122 |
| 09e1afd3-f431-4380-82c5-438884c25615 | Product name | 1 | 20190111 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 3 | 20171212 |
| 502efed8-01a5-ef6a-61c6-fe8302b6e26b | Product name | 2 | 20171113 |
| 8b700cfd-17dd-41a2-90f5-a80ae8a989a2 | Product name | 1 | 20171113 |
| 9ce0e503-4ae7-2c6a-39ae-85285c29db68 | Product name | 2 | 20171113 |
| 96bdf4b3-71cd-433d-9723-89e50f852992 | Product name | 1 | 20150810 |
| ed2e617f-f28a-1df1-f9fc-c79702f31271 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43853-0019-1 | 2021-01-15 | C162847 | 48780-1 | 9d75b9d0-6e53-f424-e053-dadaa90a57ce | ProBlen Libido |
| 43853-0019-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-6e53-f424-e053-dadaa90a57ce | ProBlen Libido |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43853-0019-1 | Libido | 30 mL in 1 BOTTLE, SPRAY | LIQUID | 30 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43853-0019 | LIBIDO (DAMIANA, GALIUM, GLANDULA SUPRARENALIS, HEPAR, HYPOPHYSIS, KOREAN GINSENG, NUPHAR, ORCHITINUM, PHOSPHORICUM AC, POPULUS TREM, TESTOSTERONE.) LIQUID [PROBLEN] | 2 | Current NDC, Legacy NDC, 1 package rows | 20210116_74669ed9-05c7-410c-95b4-985b92e000bf.zip |
Products#
Every source-derived product name is available through these pages.
- Libido
- Damiana, Galium, Glandula Suprarenalis, Hepar, Hypophysis, Korean Ginseng, Nuphar, Orchitinum, Phosphoricum ac, Populus Trem, Testosterone.
- GALIUM APARINE
- SUS SCROFA ADRENAL GLAND
- PORK LIVER
- SUS SCROFA PITUITARY GLAND
- ASIAN GINSENG
- NUPHAR LUTEA ROOT
- SUS SCROFA TESTICLE
- PHOSPHORIC ACID
- POPULUS TREMULOIDES WHOLE
- TESTOSTERONE
- ALCOHOL
- WATER
- TURNERA DIFFUSA LEAFY TWIG
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43853-0019 | 43853-0019-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GALIUM APARINE | Z4B6561488 | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| SUS SCROFA PITUITARY GLAND | E8S87O660T | ACTIB |
| ASIAN GINSENG | CUQ3A77YXI | ACTIB |
| NUPHAR LUTEA ROOT | 714LIU3V6D | ACTIB |
| SUS SCROFA TESTICLE | KM02613O28 | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| POPULUS TREMULOIDES WHOLE | MUN0TBE4PE | ACTIB |
| TESTOSTERONE | 3XMK78S47O | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| TURNERA DIFFUSA LEAFY TWIG | RQ2CFA7WWJ | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Libido | DAMIANA, GALIUM, GLANDULA SUPRARENALIS, HEPAR, HYPOPHYSIS, KOREAN GINSENG, NUPHAR, ORCHITINUM, PHOSPHORICUM AC, POPULUS TREM, TESTOSTERONE. | ProBlen | 74669ed9-05c7-410c-95b4-985b92e000bf | 2021-01-15 | Warnings | 43853-0019-1 43853-0019 43853001901 b8f74cc1-afc6-61ed-e053-2a95a90a9515 74669ed9-05c7-410c-95b4-985b92e000bf |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
